首页> 外文期刊>Japanese Journal of Clinical Oncology >Sudden-Onset Pancytopenia with Intracranial Hemorrhage after Oxaliplatin Treatment: A Case Report and Literature Review
【24h】

Sudden-Onset Pancytopenia with Intracranial Hemorrhage after Oxaliplatin Treatment: A Case Report and Literature Review

机译:奥沙利铂治疗后突然发作的全血细胞减少症伴颅内出血:一例报告并文献复习

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Oxaliplatin is a third-generation platinum compound and has been widely employed in the treatment of colorectal cancer. Despite its good efficacy, it is reported to induce immune-mediated cytopenia. We report the case of a 78-year-old male patient who experienced acute pancytopenia along with coagulopathy and intracranial hemorrhage after his 17th course of oxaliplatin. This condition appeared immediately after completion of oxaliplatin infusion, and was persistent despite aggressive transfusion and treatment with granulocyte colony-stimulating factor. The patient died 72 h after the administration of oxaliplatin. The only preceding symptom was chills 30 min after initiation of oxaliplatin, although steroid was given as premedication. We review the literature describing oxaliplatin-induced cytopenia, and discuss the manifestation, immune mechanism and treatment of this condition. We conclude that any symptoms that occur during infusion of oxaliplatin should not be overlooked but should be taken seriously as they may represent ‘a little spark that kindles a great fire’, and that steroids may provide an effective treatment for oxaliplatin-induced cytopenia. However, a major complication in our patient may still happen. Further studies for the mechanism and the predictive markers of oxaliplatin-induced cytopenia are worthy.
机译:奥沙利铂是第三代铂化合物,已广泛用于治疗大肠癌。尽管它具有良好的功效,但据报道可诱导免疫介导的血细胞减少症。我们报道了一例78岁男性患者的奥沙利铂第17个疗程后出现急性全血细胞减少症以及凝血病和颅内出血的病例。这种情况在奥沙利铂输注完成后立即出现,尽管进行了积极输注和用粒细胞集落刺激因子治疗,但仍持续存在。该患者在服用奥沙利铂后72小时死亡。以前的唯一症状是开始使用奥沙利铂后30分钟出现寒战,尽管类固醇激素是作为处方药。我们回顾了描述奥沙利铂诱导的血细胞减少症的文献,并讨论了这种疾病的表现,免疫机制和治疗方法。我们得出的结论是,输注奥沙利铂期间发生的任何症状均不应忽视,而应予以认真对待,因为它们可能代表“点燃大火的小火花”,并且类固醇可以为奥沙利铂诱导的血细胞减少症提供有效的治疗方法。但是,我们患者的主要并发症仍然可能发生。奥沙利铂诱导的血细胞减少的机理和预测标记的进一步研究是值得的。

著录项

  • 来源
    《Japanese Journal of Clinical Oncology》 |2011年第1期|p.125-129|共5页
  • 作者

    Wei-Shu Wang;

  • 作者单位

    National Yang-Ming University Hospital, @%@, Taipei Veterans General Hospital, @%@For reprints and all correspondence: Wei-Shu Wang, @%@. E-mail:;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号